Table 2. Clinical outcomes.
| Variables | After the PS match n=576 |
||||
|---|---|---|---|---|---|
| iMT | TEVAR | P value | |||
| n=480 | n=96 | ||||
| Follow-up months | 28.0 | (15.0, 53.0) | 31.0 | (11.0, 50.5) | 0.84 |
| CT follow-ups / year | 1.7 | (1.1, 2.7) | 1.8 | (1.3, 2.4) | 0.24 |
| Death | 19 | 4.0% | 3 | 3.1% | 0.70 |
| Aortic events | 70 | 14.6% | 14 | 14.6% | 1.00 |
| Type-A AD | 8 | 1.7% | 1 | 1.0% | 0.65 |
| CVD | 10 | 2.1% | 1 | 1.0% | 0.50 |
| Paraplegia | 6 | 1.3% | 1 | 1.0% | 0.87 |
| VTE | 180 | 37.5% | 37 | 38.5% | 0.85 |
| IHD | 57 | 11.9% | 6 | 6.3% | 0.11 |
| CHF | 105 | 21.9% | 20 | 20.8% | 0.82 |
| CKD | 68 | 14.2% | 18 | 18.8% | 0.25 |
| DIC | 96 | 20.0% | 27 | 28.1% | 0.08 |
| Antiplatelets | 136 | 28.3% | 18 | 18.8% | 0.05 |
| Oral anticoagulants | 82 | 17.1% | 12 | 12.5% | 0.27 |
Summary of patient outcomes in the PSM cohort (n=576), including follow-up duration, frequency of chest CT imaging, all-cause mortality, aortic-related events, and other complications. Summary in the crude cohort (n=4995) is summarized in Supplementary Table S5online supplemental table S5. Values are reported as medians with IQR for continuous variables and as counts with percentages for categorical variables.
Categorical values are reported as total numbers (%) and continuous variables as medians (IQR).
AD, aortic dissection; CHF, congestive heart failure; CKD, chronic kidney disease; CVD, cerebrovascular disease; DIC, disseminated intravascular coagulation; IHD, ischemic heart disease; iMT, initial medical therapy; PS, propensity score; PSM, PS matching; TEVAR, thoracic endovascular aortic repair; VTE, venous thromboembolism.